Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial

被引:0
|
作者
Masaya Takahashi
Kazuhiko Soejima
Shoichiro Taniuchi
Yasuko Hatano
Sohsaku Yamanouchi
Hideki Ishikawa
Makoto Irahara
Youhei Sasaki
Hiroshi Kido
Kazunari Kaneko
机构
[1] Kansai Medical University,Department of Pediatrics
[2] Graduate School of Medical Science,Department of Molecular
[3] Kyoto Prefectural University of Medicine,Targeting Cancer Prevention
[4] Institute of Biomedical Sciences,Department of Pediatrics
[5] Tokushima University Graduate School,Division of Enzyme Chemistry
[6] Institute for Enzyme Research,Department of Pediatrics
[7] Tokushima University,undefined
[8] Takatsuki General Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
引用
收藏
相关论文
共 50 条
  • [1] Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
    Masaya Takahashi
    Kazuhiko Soejima
    Shoichiro Taniuchi
    Yasuko Hatano
    Sohsaku Yamanouchi
    Hideki Ishikawa
    Makoto Irahara
    Youhei Sasaki
    Hiroshi Kido
    Kazunari Kaneko
    Scientific Reports, 7
  • [2] Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial
    Takahashi, Masaya
    Soejima, Kazuhiko
    Taniuchi, Shoichiro
    Hatano, Yasuko
    Yamanouchi, Sohsaku
    Ishikawa, Hideki
    Irahara, Makoto
    Sasaki, Youhei
    Kido, Hiroshi
    Kaneko, Kazunari
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Oral immunotherapy combined with omalizumab for high-risk cow's milk allergy: a randomized controlled trial (vol 7, 17453, 2018)
    Takahashi, Masaya
    Soejima, Kazuhiko
    Taniuchi, Shoichiro
    Hatano, Yasuko
    Yamanouchi, Sohsaku
    Ishikawa, Hideki
    Irahara, Makoto
    Sasaki, Youhei
    Kido, Hiroshi
    Kaneko, Kazunari
    SCIENTIFIC REPORTS, 2018, 8
  • [4] A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy
    Wood, Robert A.
    Kim, Jennifer S.
    Lindblad, Robert
    Nadeau, Kari
    Henning, Alice K.
    Dawson, Peter
    Plaut, Marshall
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (04) : 1103 - +
  • [5] A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing
    Kim, Jennifer S.
    Wood, Robert A.
    Lindblad, Robert
    Noone, Sally A.
    Paterakis, Melissa N.
    Henning, Alice
    Nadeau, Kari C.
    Spann, Kyrsten
    Sampson, Hugh A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB403 - AB403
  • [6] Adverse Events in Oral Immunotherapy for the Desensitization of Cow's Milk Allergy in Children: A Randomized Controlled Trial
    De Schryver, Sarah
    Mazer, Bruce
    Clarke, Ann E.
    St Pierre, Yvan
    Lejtenyi, Duncan
    Langlois, Alexandra
    Torabi, Bahar
    Zhao, Wei W.
    Chan, Edmond S.
    Baerg, Ingrid
    Ben-Shoshan, Moshe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1912 - 1919
  • [7] Safety of Oral Immunotherapy Associated With Omalizumab In Severe Cow's Milk Allergy
    Sousa, Ana Flavia
    Yang, Ariana
    Mendes, Cintia G.
    Boufleur, Karine
    Torres, Pablo
    Salles-Cunha, Patricia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB133 - AB133
  • [8] A case of cow's milk allergy treated with rush oral immunotherapy with omalizumab
    Iwasaki, Yasushi
    Okada, Yuki
    Imai, Tananori
    PEDIATRICS INTERNATIONAL, 2024, 66 (01)
  • [9] Oral Immunotherapy Using Partially Hydrolyzed Formula for Cow's Milk Protein Allergy: A Randomized, Controlled Trial
    Inuo, Chisato
    Tanaka, Kenichi
    Suzuki, Satoko
    Nakajima, Yoichi
    Yamawaki, Kazuo
    Tsuge, Ikuya
    Urisu, Atsuo
    Kondo, Yasuto
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 177 (03) : 259 - 268
  • [10] Oral immunotherapy with omalizumab in patients with severe persistent allergy to cow's milk proteins
    Penalver Hernandez, M. J.
    Moya, B.
    Marin, L.
    Crespo, J. F.
    Dieguez, M. C.
    ALLERGY, 2020, 75 : 524 - 524